AAIM
American Assets Investment Management Portfolio holdings
AUM
$1.24B
This Quarter Return
-0.5%
1 Year Return
+216.47%
3 Year Return
+316.36%
5 Year Return
+491.45%
10 Year Return
+587.47%
AUM
$334M
AUM Growth
+$334M
(+6.8%)
Cap. Flow
+$24.1M
Cap. Flow
% of AUM
7.21%
Top 10 Holdings %
Top 10 Hldgs %
42.02%
Holding
117
New
7
Increased
13
Reduced
1
Closed
1
Top Buys
| 1 |
AAT
American Assets Trust
AAT
|
$10.8M |
| 2 |
GE Aerospace
GE
|
$9.69M |
| 3 |
CONE
CyrusOne Inc Common Stock
CONE
|
$2M |
| 4 |
Bank of Montreal
BMO
|
$1.48M |
| 5 |
Bank of America
BAC
|
$1.05M |
Top Sells
| 1 |
Medtronic
MDT
|
$5.3M |
| 2 |
AbbVie
ABBV
|
$1.16M |
Sector Composition
| 1 | Financials | 28.29% |
| 2 | Real Estate | 13.97% |
| 3 | Healthcare | 12.85% |
| 4 | Energy | 11.94% |
| 5 | Technology | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Wells Fargo
WFC
$263B
| $50.4M | 15.08% | 896,000 | – | – |
|
|
AAT
2
American Assets Trust
AAT
$1.28B
| $29.6M | 8.86% | 755,124 +275,785 | +58% | +$10.8M |
|
3
JPMorgan Chase
JPM
$829B
| $10.5M | 3.15% | 155,510 | – | – |
|
|
4
GE Aerospace
GE
$292B
| $9.69M | 2.9% | +364,850 | New | +$9.69M |
|
5
BP
BP
$90.8B
| $8.44M | 2.53% | 211,316 +11,209 | +6% | +$448K |
|
6
Apple
AAPL
$3.45T
| $6.59M | 1.97% | 52,500 | – | – |
|
7
Verizon
VZ
$186B
| $6.53M | 1.95% | 140,000 | – | – |
|
8
Unilever
UL
$155B
| $6.44M | 1.93% | 150,000 | – | – |
|
9
General Motors
GM
$55.8B
| $6.11M | 1.83% | 183,420 +20,000 | +12% | +$667K |
|
10
Chevron
CVX
$324B
| $6.09M | 1.82% | 63,170 | – | – |
|
11
American International
AIG
$45.1B
| $5.96M | 1.78% | 96,320 +15,000 | +18% | +$927K |
|
12
Johnson & Johnson
JNJ
$427B
| $5.39M | 1.61% | 55,320 | – | – |
|
13
Novartis
NVS
$245B
| $5.09M | 1.52% | 51,760 | – | – |
|
14
HP
HPQ
$26.7B
| $4.9M | 1.47% | 163,290 +10,000 | +7% | +$300K |
|
15
Microsoft
MSFT
$3.77T
| $4.87M | 1.46% | 110,240 | – | – |
|
|
WBA
16
DELISTED
Walgreens Boots Alliance
WBA
| $4.58M | 1.37% | 54,260 | – | – |
|
17
Merck
MRK
$210B
| $4.28M | 1.28% | 75,100 | – | – |
|
18
Baxter International
BAX
$12.7B
| $4.2M | 1.26% | 60,000 | – | – |
|
|
RDS.A
19
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $4.19M | 1.25% | 73,572 +1,091 | +2% | +$62.2K |
|
|
TCO
20
DELISTED
Taubman Centers Inc.
TCO
| $4.04M | 1.21% | 58,125 | – | – |
|
21
Simon Property Group
SPG
$59B
| $3.93M | 1.18% | 22,700 | – | – |
|
22
Pfizer
PFE
$141B
| $3.86M | 1.15% | 115,000 | – | – |
|
|
EMC
23
DELISTED
EMC CORPORATION
EMC
| $3.72M | 1.11% | 141,000 | – | – |
|
24
Oracle
ORCL
$635B
| $3.7M | 1.11% | 91,870 | – | – |
|
25
MetLife
MET
$54.1B
| $3.48M | 1.04% | 62,144 | – | – |
|